Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.
about
External counterpulsation for acute ischaemic strokePercutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic strokeExternal counterpulsation for acute ischaemic strokeEffectiveness of regionalized systems for stroke and myocardial infarctionThe Role of the PI3K Pathway in the Regeneration of the Damaged Brain by Neural Stem Cells after Cerebral InfarctionManagement of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsWhat is the Role for Intra-Arterial Therapy in Acute Stroke Intervention?Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom OnsetRegulatory T cell in stroke: a new paradigm for immune regulationThe exact science of stroke thrombolysis and the quiet art of patient selectionTelemedicine in pre-hospital care: a review of telemedicine applications in the pre-hospital environmentCell based therapies for ischemic stroke: from basic science to bedsideTargeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain InjuryProtective and detrimental effects of neuroectodermal cell–derived tissue factor in mouse models of strokeIntravenous versus intra-arterial thrombolysis in ischemic stroke: a systematic review and meta-analysis.Immunomodulation after ischemic stroke: potential mechanisms and implications for therapySystematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic strokeCocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?Preserved Collateral Blood Flow in the Endovascular M2CAO Model Allows for Clinically Relevant Profiling of Injury Progression in Acute Ischemic StrokeRe-endovascular recanalization for acute middle cerebral artery reocclusion after surgical embolectomy.Management of ischaemic stroke in the acute setting: review of the current status.Endovascular thrombectomy following acute ischemic stroke: a single-center case series and critical review of the literature.Simultaneous bilateral real-time 3-d transcranial ultrasound imaging at 1 MHz through poor acoustic windows.Pitch-catch phase aberration correction of multiple isoplanatic patches for 3-D transcranial ultrasound imaging.A fibrin-specific thrombolytic nanomedicine approach to acute ischemic strokeThe ultrasound brain helmet: new transducers and volume registration for in vivo simultaneous multi-transducer 3-D transcranial imagingPotentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®))Fibrinolytic therapy in acute stroke.Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study.Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors.A review of current imaging methods used in stroke research.Who does it first? The uptake of medical innovations in the performance of thrombolysis on ischemic stroke patients in Germany: a study based on hospital quality data.Data science of stroke imaging and enlightenment of the penumbra.Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombusBeneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in RatsThrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.Rapid Short MRI Sequence Useful in Eliminating Stroke Mimics Among Acute Stroke Patients Considered for Intravenous ThrombolysisIntra-arterial therapy for acute ischemic stroke.
P2860
Q24203891-BEBD5BB8-4CBB-4043-9246-FF8C04E7C77AQ24234840-1449DEC1-B268-44DB-AD54-58EF38C2AB27Q24235108-58EBDECF-F21B-45C4-87D0-7EB1D0D37834Q26777840-EB541E0A-83F2-45F8-8017-25FBEA3EBDB5Q26796283-DA5517E7-0B61-4713-B5D3-975A60F441DFQ26796470-ADADF943-BB19-4A06-A168-9C45F8586CADQ26796472-323A6F9F-F31D-4B0D-BAA5-34DEBD27BFA7Q26796477-295E09D5-18E4-4692-A5DC-D4813EFF5D66Q26995751-02CE26EF-B445-4DEB-ADD9-DC4B0BEFFEBAQ27011873-A26B0D79-F231-4748-ADF3-6B1CA126D510Q27023617-5EFF1320-AA4A-4235-A545-A3C1E54F10A4Q27025754-E6D694AA-399D-4D9B-92C0-FCA1C84255A9Q27304584-8C4A5BE5-CC93-4C65-BC1C-84DF43364B74Q27333861-740108FE-F9CC-4E49-960A-103CD23CD9C8Q27692041-B68CE4B3-439D-4A13-9407-E3F4BB42A0E2Q28071656-24793274-C0CB-41AB-81A2-E7A8786DCCF0Q28073784-5E30174F-9535-4AA5-9F02-4633F097313DQ28077232-B208314A-A1AE-45E9-A3F2-C7BF4624F4CAQ28469502-16D89084-CE49-43BA-BF6D-D03F55B7FE50Q30413736-068EAC16-45F7-4CFD-872C-89FBF83348C8Q30431467-7EC724D4-FF56-4CA2-88FF-B163451654ADQ30436396-753BE165-8B96-4984-BED4-9172B94990FBQ30441014-45BC43FA-4177-4451-9853-B585C8356C36Q30442309-C63B0EB4-AE7D-4D0F-A1F2-171E19817177Q30452739-A3BED736-ACA1-4763-A502-33F54B2716BBQ30470770-5A2717AC-024E-48FF-B739-3A939533F8D6Q30471810-1462D229-28A4-48DE-824E-C0BC699EA6BBQ30474632-FFDD7566-7C63-4C36-8965-ED9C9042161FQ30501009-7D27D8DD-5A32-404A-BB9C-F4B477299CD1Q30586518-459505D0-A63C-40C2-AF8D-E0C5B930AD6CQ30670310-02951A34-2C77-4849-A506-B7F673C02640Q30884217-EFB48987-1040-4D55-83E8-2F23753C0E6EQ30914023-67F7465A-C519-4538-A17D-A90233E51768Q33389941-992A5539-EB06-4C84-868A-242332847D90Q33566724-C27A4C32-977D-44B0-B7F2-89EC719FB595Q33577748-C26386E1-3FF1-4515-8E71-7EAD6AFB0C31Q33583533-653E7ADB-9E2E-4774-B8AF-E7944768F9E2Q33593063-FCA87068-4F2E-4F09-A7B2-2E519AA475C6Q33615129-68809FDE-3354-4F1E-99C1-E7967A8EF4BFQ33653028-4F8B7DC7-6E7E-4B90-A1C7-53D9499667F5
P2860
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expansion of the time window f ...... n/American Stroke Association.
@en
Expansion of the time window f ...... n/American Stroke Association.
@nl
type
label
Expansion of the time window f ...... n/American Stroke Association.
@en
Expansion of the time window f ...... n/American Stroke Association.
@nl
prefLabel
Expansion of the time window f ...... n/American Stroke Association.
@en
Expansion of the time window f ...... n/American Stroke Association.
@nl
P2093
P2860
P1433
P1476
Expansion of the time window f ...... on/American Stroke Association
@en
P2093
American Heart Association Stroke Council
Gregory J Del Zoppo
Harold P Adams
P2860
P304
P356
10.1161/STROKEAHA.109.192535
P407
P577
2009-05-28T00:00:00Z